Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias Meeting Abstract

  

Authors:	Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; Shah, U.; Maclachlan, K.; Tan, C. R.; Usmani, S.; Stetson, P.; Giralt, S.; Scordo, M.
Abstract Title:	Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias
Meeting Title:	20th Annual Meeting and Exposition of the International Myeloma Society
Journal Title:	Clinical Lymphoma, Myeloma and Leukemia
Volume:	23
Issue:	Suppl. 2
Meeting Dates:	2023 Sep 27-30
Meeting Location:	Athens, Greece
ISSN:	2152-2650
Publisher:	Elsevier Inc.
Date Published:	2023-09-01
Start Page:	S306
Language:	English
ACCESSION:	WOS:001079705400535
PROVIDER:	wos
DOI:	10.1016/S2152-2650(23)02101-8
Notes:	Meeting Abstract: P-484 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/211921